Prader-Wil and Angelman syndromes are complex neurobehavioral contiguous gene syndromes whose expression depends on the unmasking of genomic imprinting for different genetic loci in human chromosome 15q11-q13. The homologous chromosomal region in the mouse genome has been fine-mapped by using interspecific (Mus spretus) crosses and overlapping, radiation-induced deletions to evaluate potential animal models for both imprinted and nonimprinted components of these syndromes. Four evolutionarily conserved sequences from human 15q11-q13, induding two cDNAs from fetal brain (DN10, D1SS12h; DN34, DlSS9h-1), a microdissected clone (MN7; DISF37Slh) expressed in mouse brain, and the gene for the (33 subunit of the -aminobutyric acid type A receptor (Gabrb3), were mapped in mouse chromosome 7 by analysis of deletions at the pink-eyed dilution (p) locus.
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are clinically distinct disorders with complex developmental and neurological phenotypes often associated with cytogenetically visible deletions of human chromosome 15q11-q13, which are indistinguishable in extent (reviewed in ref. 1) . PWS infants display hypotonia and a failure to thrive, which is then followed, 2-4 years later, by hyperphagia with consequent obesity, behavioral disorders, mild to moderate mental retardation with learning disabilities, hypogonadism, short stature, and mild facial dysmorphism (2) . AS patients manifest severe mental retardation, absent speech, inappropriate laughter, puppet-like ataxic movements, microbrachycephaly, seizures, an abnormal electroencephalogram, mild hypotonia, and prognathism with tongue protrusion (3) . Genomic imprinting plays a major role in the manifestation of PWS and AS (1) . About 60-70% of PWS or AS patients carry a 15q11-q13 deletion that is of paternal or maternal origin, respectively, but the deletion is not cytogenetically different in the two cases. Likewise, most chromosomally normal PWS patients are characterized by uniparental maternal disomy for chromosome 15 , and a few chromosomally normal AS patients have uniparental paternal disomy (1) . In contrast, the remaining cytogenetically normal (biparental) AS patients may be mutant for a gene in the maternally derived 15q11-q13 (4, 5) , and AS has been found in a family segregating for a submicroscopic chromosome 15 deletion that includes the gene for the 633 subunit of the y-aminobutyric acid (GABA) type A receptor (GABRB3). No cases of PWS occurred in this family, suggesting that the critical region within 15q11-q13 is different for AS and PWS (6) .
Because both PWS and AS are often associated with cytogenetically detectable deletions, they are good examples of contiguous gene syndromes (7) . The number and function of genes responsible for each of the distinct phenotypes often exhibited by AS or PWS patients as well as the pattern of expression in different cell types of such genes are all unknown. Indeed, it is not yet completely understood whether all ofthe major phenotypes observed in PWS and AS are the result ofan extremely pleiotropic mutation at a single, imprinted locus or are due to the combined effects ofdeletion or misexpression of both imprinted and nonimprinted 15qll-q13 loci. Thus, a full understanding of the genetic mechanisms and pathogenesis during development of PWS and AS, as well as of the role(s) of genomic imprinting, would be greatly aided by animal models, of which the mouse is highly suitable. Low-resolution mapping analyses using recombinant inbred strains have demonstrated that DNA clones derived from human chromosome l5qll-q13 identify loci in the mouse that are linked to the region containing the pink-eyed dilution (p) locus in chromosome 7 (8) (9) (10) (11) (12) . Here, we present a higher-resolution map of the p region, based on interspecific backcross (IB) analysis and deletion mapping, that refines the homology map of human chromosome 15qll-q13 and the mouse p region. This refined map should be useful for relating genes and phenotypes identified in the mouse directly to the task of dissecting the components of PWS, AS, and possibly other disorders associated with alterations in human 15q11-q13. ITo whom reprint requests should be addressed.
MATERIALS AND METHODS
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were imported to Oak Ridge National Laboratory from The Jackson Laboratory and from V. Chapman (Roswell Park Memorial Institute, Buffalo, NY), respectively. All other mice originated and are maintained at Oak Ridge National Laboratory. Viable and lethal mutations at the chromosome 7 pink-eyed dilution (p) locus were recovered in the progeny of mutagen-exposed animals crossed to a tester stock marked with seven recessive mutations, including the original p mutation of the mouse fancy (see ref. 13 DNA Probes. Two human cDNAs (DN10 and DN34) isolated from a human fetal brain library (8, 15, 16 ) and a microdissected clone (MN7) (17) from chromosome 15qll-q13, as well as a human cDNA to MYODI (14) and mouse cDNAs to Igflr (18) and 34-1-111 (see below), were used in these studies. A GABRB3 probe (designated 218/219) was prepared by PCR with primers for rat genomic DNA (19) . Molecular Analyses. DNA was prepared from spleen, liver, or fetuses by standard methods (20) . Genomic DNA (3-10 ,ug) was digested with restriction enzymes, and DNA fragments were separated by agarose gel electrophoresis, transferred to nylon membranes, prehybridized, and hybridized as described elsewhere (15, 20) . Membranes were washed at 56°C for mouse DNA probes or 42°C for human DNA probes in 0.lx SSC (0.015 M NaCl/0.0015 M sodium citrate)/0.1% SDS. Procedures for preparation of RNA and Northern blots have been described elsewhere (15, 20) .
cDNA Cloning. Poly(A)+ mRNA was prepared from the cerebellum, cortex, hypothalamus, and hippocampus ofadult female CD-1 mice (Charles River Breeding Laboratories), and cDNA was synthesized following priming with random hexamers according to standard procedures (20) . cDNA was made blunt-ended with T4 DNA polymerase, internal EcoRI sites were protected by methylation with EcoRI metbvlase, and phosphorylated EcoRI linkers were added. After digestion with EcoRI, the cDNA was ligated into EcoRI-digested, phosphatased arms of Lambda ZAP II (Stratagene), packaged, plated on XL1-Blue bacteria, and screened by plaque hybridization with radiolabeled DN34. Inserts from purified, positive phage were subcloned by direct excision from Lambda ZAP II, according to the manufacturer.
RESULTS
Isolation of a Mouse cDNA to a Candidate Imprinted Human Gene DiSS9 and Its Tight Linkage to p in Mouse Chromosome 7. The human DN34 cDNA clone, which detects a DNA methylation imprint at the D1SS9 locus in humans (16) , recognizes several related loci in the mouse genome (9, 11) . Using analysis of recombinant inbred strains and flow-sorted chromosomes, one DN34-related locus was mapped to chromosome 5, near Bcd-1, and one was mapped to chromosome 7 (9), while a mouse genomic clone (D7Hmsl), isolated by hybridization to DN34, was mapped to chromosome 7 closely linked to the 15q11-q13 locus DlSS12h (formerly designated D7Nicl) (11) . To determine the map position of this chromosome 7 locus more precisely, we used DN34 to isolate a 1.2-kb mouse cDNA, designated 34-1-111, from an adult brain library (see Materials and Methods). Fig. 1 A and B shows that while the human cDNA DN34 recognizes several fragments in restriction enzyme-digested mouse DNA, the mouse cDNA 34-1-111 detects a single fragment. In each case, this single fragment is the most intensely hybridizing fragment detected by DN34.
To determine whether the 34-1-111 cDNA recognizes the homolog of the human 15q11-q13 locus D15S9, we tested whether a restriction fragment length variant (RFLV) (9, 11, 12 ) that the D1SF37S1h (formerly designated D7Nic2 orD1SF32S1h) and Gabrb3 loci were closely linked to D15S12h by analysis of recombinant inbred strains, suggested that these human 15qll-ql13-related loci might be deleted in pre-or neonatally lethal, radiation-induced p-locus mutations. We had previously shown that D15S12h (DN10) is deleted in a number of radiation-induced p mutations (15) . Thus, we tested for deletion of the D15F37Sh (probe MN7), Gabrb3 (218/219), and D15S9h-1 (34-1-111) loci in DNA derived from mice carrying several lethal p-locus mutations balanced opposite a M. spretus chromosome 7. Fig. 2A shows the analysis of a Taq I RFLV (2.5 kb in Mus musculus DNA and 2.7 kb in M. spretus DNA) at the D1SF37Slh locus, a Pst I RFLV (3.6 kb in M. musculus DNA and 1.8 kb in M. spretus DNA) at the Gabrb3 locus, and the EcoRI RFLV (see above) at the D15S9h-1 locus. The D1SF37SJh locus, but not the Gabrb3 and DlSS9h-1 loci, is deleted in the prenatally lethal p3R30M and p46DFiOD deletions. The p46DFiOD mutation also deletes the entire p (D15S2h; DN10) transcription unit (15) and the proximal marker Myod-l (14) , whereas the p3R30m mutation does not delete Myod-l (E.M.R. and L.B.R., unpublished data). The D1SS9h-1 locus is not deleted in any of these mutations, and of these three tested loci, only Gabrb3 is deleted in p4THO-lI. Fig. 2B shows that the p4THO-ll deletion interrupts the p (DlSS12h) transcription unit, because in DNA obtained from p4THOI/p4THO-4I homozygotes, which die perinatally (E.M.R. and L.B.R., unpublished data), the DN10 cDNA clone detects only a subset of the fragments present in wild-type DNA. Fig. 2C shows the results of sequential rehybridization of MN7, 218/219, and 34-1-111, respectively, to Southern blots of DNA from mice homozygous for two other mutations, p 7FR60Lb, which die perinatally (E.M.R. and L.B.R., unpublished data) andp6H, which often live to juvenile stages and beyond, and are characterized by small size, nervous behavior, and male sterility (21). D1SF37Sh is deleted in both p6H and p7FR60Lb; the Gabrb3 probe 218/219 is deleted in p7FR60Lb but not in p6H; and neither mutation deletes the DlSS9h-1 sequence recognized by 34-1-111. Fig. 3 presents a map of the Myod-l-Igflr region of chromosome 7 based on the deletion-mapping data. The orientation ofthe map is based on the facts that (i) IB analysis places D15S9h-1 distal top, (ii) the p46DFiOD deletion includes Myod-l (14) but not the segment of the Gabrb3 locus defined by the 218/219 probe, and (iii) p4THO-II breaks within the D15S12h (p) transcription unit and includes Gabrb3 but not DlSF37Slh. The map in Fig. 3 also shows a locus (pl) representing one of a number of genes probably required for prenatal development that are defined by prenatally lethal p deletions (ref. 22 ; L.B.R. and E.M.R., unpublished data).
The Gabrb3 Gene Is Not Involved in the Neurological Phenotype Observed in p6H Homozygotes. As noted previously, mice homozygous for the p6H mutation are runty, male sterile, and typically manifest a nervous, quivering behavior (21) . The results presented in Fig. 2C demonstrate that the p6H deletion does not affect the sequence represented by the 218/219 probe at the Gabrb3 locus. However, because this probe is only a small part of the total Gabrb3 cDNA, it was still possible that the p6H deletion disrupts expression of the Gabrb3 gene. This possibility was tested by hybridizing the 218/219 probe to Northern blots of poly(A)+ RNA prepared from brains of p6H homozygotes and heterozygotes. Fig. 4 demonstrates that the predominant 5.5-kb Gabrb3 transcript is expressed in p6H/p6H mice. As expected from the data in Fig. 2C , the -14-kb transcript detected by the MN7 probe at the D1SF37SJh locus (17) is not expressed in the brains of p6H/p6H mice.
The Gabrb3 Locus Is Not Parentafly Imprinted in Mouse
Brain. Deletion of at least a segment of the Gabrb3 coding region in the p4THOII mutation ( Fig. 2A) made it possible to test directly whether the expression of this gene is parentally imprinted. Because GABRB3 in humans maps to the AS critical region (ANCR; refs. 6 and 19), a determination of whether the expression of this gene is imprinted in mouse might provide supporting evidence for any role of GABRB3 in AS. Consequently, the 218/219 probe was hybridized to Northern blots of total RNA prepared from the brains of p4THO0-4/p mice that had inherited the deletion from either the dam or the sire. Fig. 5 demonstrates that the Gabrb3 gene is expressed equally well from either the maternal or paternal chromosome (i.e., from the chromosome derived from the 129/RI parent in either case), a result consistent with the fact that the p4THOII deletion can be passed through either parent without any phenotypic consequence (E.M.R. and L.B.R., unpublished data). 
DISCUSSION
Mapping offour evolutionarily conserved human loci in lethal p-locus mutations in mice has demonstrated conservation of fine-structure synteny between human chromosome 15qll-q13 and the p region of mouse chromosome 7. This conservation of both gene content and gene order suggests that mutations in the mouse p region may serve well as experimental reagents with which to dissect the complex phenotypes ofthe contiguous gene syndromes PWS and AS. For example, the only significant clinical difference between PWS and AS patients who carry a cytogenetically detectable deletion versus those that do not is that hypopigmentation ofthe skin, hair, and eyes is often observed in the patients with the deletion (23, 24) . The suggestion that the DJSS12 locus is the human homolog ofthe p gene in mice and is likely associated with the hypopigmentation sometimes observed in PWS/AS patients who carry cytogenetically detectable deletions (15, 25) , as well as the finding that both copies ofD15SS2 are mutated in at least one patient with tyrosinase-positive oculocutaneous albinism (15) , provides an illustrative example of the use of mouse mutations for identifying individual components of human contiguous gene syndromes.
Any major gene(s) that contributes to phenotypes unique to either AS or PWS must be imprinted (1) . Deletion of the (33 subunit of the GABA receptor (GABRB3) in a family segregating AS (6) has made this gene a candidate for the primary defect in AS (6, 19) . GABA is an inhibitory neurotransmitter in the mammalian adult central nervous system, although a role in excitatory transmission of neonatal hippocampal neurons has recently been suggested (26) . However, it is not yet known whether GABRB3 is imprinted in humans. We have shown that Gabrb3 is not parentally imprinted in mouse brain and that mice hemizygous for the gene are phenotypically normal. Others have made similar observations in mice with maternal uniparental disomy of this segment of mouse chromosome 7 (31) . If imprinting of specific genes is conserved throughout evolution, as is the case for the H19 gene in mouse and human (27) which does contain the GABRB3 gene, is >650 kb and has the potential to encode many other genes.
One gene from human 15q11-q13 that may be imprinted is the proximally mapping locus D15S9, identified by the DN34 cDNA. This gene demonstrates a differential DNA methylation imprint between parental chromosomes in humans (16) , but further work is required to show whether the gene is functionally imprinted. The homologous locus in the mouse, DlSS9h-1, identified by the mouse 34-1-111 cDNA clone, maps distal to p, between Gabrb3 and Igflr (Fig. 3) , and is not deleted in any p deletion reported here. In fact, we have evidence (E.M.R., unpublished data) that this locus is not deleted in any of 31 p deletions tested to date, an unexpected result considering that D1SS9h-J is only 1.1 + 0.8 cM from p. Because the majority of these deletions were derived from mutagenized paternal genomes (E.M.R. and L.B.R., unpublished data), it is tempting to speculate that D15S9h-J or a closely linked locus may be functionally imprinted in the mouse and that deletion of this region may be a dominantlethal event.
Defects at the Gabrb3 locus cannot be the cause of the abnormal neurological phenotype (21) exhibited by mice homozygous for the p6H deletion since brains of these animals express the Gabrb3 transcript at normal levels. In this context, it is intriguing that p6H/p6H mice are deleted for the D1SF37Slh locus and, therefore, do not express the highmolecular-weight transcript in brain that is identified by the MN7 microdissection clone ( Fig. 4; ref. 17 ). p6H/p4THO-I compound heterozygotes are normal in viability, behavior, and fertility, which demonstrates that the p6H neurological/ reproductive syndrome maps proximal to p, within the region anchored by the expressed D1SF37Slh locus (Fig. 3) . If phenotypes observed in the p6H syndrome are homologous to any nonimprinted components of PWS, AS, or expanded syndromes observed in patients with deletions extending distally to D15S12 (29, 30) , loci included inp6H, or in deletions extending more proximally, could possibly be correlated with components of the corresponding human syndome. Because Myod-l maps to human ilpiS (14) , it will be important to determine the proximal extent of the human 15q11-q13 homology within the mouse Myod-1-DISF37S1h interval. Thus, any new phenotypes or expressed loci identified by proximally extending p deletions could then be correlated with the appropriate human genomic region (15q11-q13, llp1S, or others), with subsequent evaluation of such phenotypes and/or loci as models for disorders mapped to that region.
When considering the degree of mutational pleiotropy often observed in human genetic syndromes associated with chromosomal deletions, it will be necessary to distinguish between true pleiotropy, caused by defects at a single locus, and apparent pleiotropy, which might be defined as the manifestation ofalterations at a number ofloci, as can happen in contiguous gene syndromes. Use of the mouse as an intermediate reagent for studying a multigenic disorder, such as in the analysis of the components of PWS, AS, or other human 15q11-q13 disorders, as reported here, should prove to be one tractable strategy for addressing this question.
